End-of-life prognostic indicators in patients with COPD: Part 1

被引:0
|
作者
Gleeson, Aoife [1 ]
Parry, Andy [2 ]
Higginson, Ray [2 ]
机构
[1] Ysbyty Ystrad Fawr, Palliat Med, Ystrad Mynach, Wales
[2] Univ South Wales, Sch Care Sci, Crit Care, Glyntaf Campus, Newport, Gwent, Wales
关键词
Chronic obstructive pulmonary disease; Biomarkers; End of life; Chronic respiratory disease;
D O I
10.12968/ijpn.2016.22.10.508
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
In the UK, chronic respiratory diseases cause 13% of adult disability. The major chronic respiratory disease is chronic obstructive pulmonary disease (COPD), a condition involving chronic airway inflammation that causes airflow obstruction and destruction of lung tissue. This leads to a progressive loss of respiratory membrane, which accounts for the clinical manifestation of COPD, which is difficulty maintaining sufficient gas exchange to meet metabolic demands. The primary cause is smoking, with the vast majority of COPD patients having a past or present history of smoking. However exposure to industrial pollutants is also a contributing factor, as is a rare genetic predisposition to developing COPD.
引用
收藏
页码:508 / 514
页数:7
相关论文
共 50 条
  • [21] Assessment of end-of-life indicators of vacuum arc thrusters
    James Saletes
    Minkwan Kim
    Journal of Electric Propulsion, 4 (1):
  • [22] Shortlist of Quality Indicators for End-of-Life Cancer Care
    O'Hanlon, Claire E.
    Walling, Anne M.
    Lindvall, Charlotta
    JAMA ONCOLOGY, 2020, 6 (07) : 1118 - +
  • [23] Quality indicators for end-of-life care in vulnerable elders
    Wenger, NS
    Rosenfeld, K
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (08) : 677 - 685
  • [24] End-of-life indicators based on temperature switchable nanobombs
    Hamberger, Anika
    Popa, Ana-Maria
    Rossi, Rene M.
    Kattnig, Daniel R.
    Hinderberger, Dariush
    Landfester, Katharina
    Crespy, Daniel
    JOURNAL OF MATERIALS CHEMISTRY, 2012, 22 (19) : 9909 - 9920
  • [25] Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer
    Hiramoto, Shuji
    Tamaki, Tomoko
    Nagashima, Kengo
    Hori, Tetsuo
    Kikuchi, Ayako
    Yoshioka, Akira
    Inoue, Akira
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (04) : 454 - 459
  • [26] Patient-physician communication about end-of-life care for patients with severe COPD
    Curtis, JR
    Engelberg, RA
    Nielsen, EL
    Au, DH
    Patrick, DL
    EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (02) : 200 - 205
  • [27] Palliative care utilization in patients with severe COPD and its associations with end-of-life care
    Freund, Ophir
    Sror, Neta
    Melloul, Ariel
    Tiran, Boaz
    Bornstein, Gil
    Zornitzki, Lior
    Bar-Shai, Amir
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [28] Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer
    Shuji Hiramoto
    Tomoko Tamaki
    Kengo Nagashima
    Tetsuo Hori
    Ayako Kikuchi
    Akira Yoshioka
    Akira Inoue
    International Journal of Clinical Oncology, 2019, 24 : 454 - 459
  • [29] Prognostic impact of end-of-life chemotherapy in the last weeks for patients with advanced cancer
    Hiramoto, S.
    Kikuch, A.
    Hori, T.
    Yoshioka, A.
    Tamaki, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] A Randomized Trial to Improve Communication About End-of-Life Care Among Patients With COPD
    Au, David H.
    Udris, Edmunds M.
    Engelberg, Ruth A.
    Diehr, Paula H.
    Bryson, Christopher L.
    Reinke, Lynn E.
    Curtis, J. Randall
    CHEST, 2012, 141 (03) : 726 - 735